NISCAIR Online Periodicals Repository

NISCAIR ONLINE PERIODICALS REPOSITORY (NOPR)  >
NISCAIR PUBLICATIONS >
Research Journals >
Indian Journal of Biotechnology (IJBT) >
IJBT Vol.07 [2008] >
IJBT Vol.07(4) [October 2008] >


Title: Cloning and expression of FMDV-VP1 immunoreactive peptide in trivalent form and its application as immunogen
Authors: Nagarajan, G
Kumar, C Ashok
Dechamma, H J
Reddy, G R
Ganesh, K
Suryanarayana, V V S
Keywords: Trivalent immunogen
FMDV
Immunoreactive
Proteins
Vaccine
Issue Date: Oct-2008
Publisher: CSIR
Abstract: A search for alternatives to conventional inactivated virus vaccine for FMD with an aim to control and eradicate the disease globally, is a continuous process till a promising one is identified. Development of such vaccines underlines necessity of avoiding the use of active virus, and to have broader antigenic coverage so as to make them suitable even for disease free countries. Subunit or peptide vaccines have been shown to elicit neutralizing antibody response. However, the titres are low as compared to sera from animals vaccinated with conventional vaccine and fail to protect animals against virus challenge. This is probably due to the inclusion of only limited epitopes. Under such conditions, mixing heterologous epitopes from the various serotypes may be a better approach for elicitation of high titred antibody response. Keeping this in view, we have linked C-terminal half of VP1 carrying two B cell and one T cell epitope of three FMDV serotypes (O, A and Asia 1), which are presently in use as vaccine strains in India. The linked polyvalent gene was expressed in Escherichia coli and the 59 kDa fusion protein was studied for its immunogenicity in guinea pigs in comparison with the specific epitopes of type ‘O’ produced as a similar fusion protein of 30 kDa. The trivalent protein showed better neutralizing antibody response, even with single booster injection, as compared to monovalent protein as observed in ELISA and SNT. These studies show future scope for the development of protein/DNA-based vaccine for FMD.
Page(s): 472-477
ISSN: 0972-5849
Source:IJBT Vol.07(4) [October 2008]

Files in This Item:

File Description SizeFormat
IJBT 7(4) 472-477.pdf477.52 kBAdobe PDFView/Open
 Current Page Visits: 735 
Recommend this item

 

National Knowledge Resources Consortium |  NISCAIR Website |  Contact us |  Feedback

Disclaimer: NISCAIR assumes no responsibility for the statements and opinions advanced by contributors. The editorial staff in its work of examining papers received for publication is helped, in an honorary capacity, by many distinguished engineers and scientists.

CC License Except where otherwise noted, the Articles on this site are licensed under Creative Commons License: CC Attribution-Noncommercial-No Derivative Works 2.5 India

Copyright © 2012 The Council of Scientific and Industrial Research, New Delhi. All rights reserved.

Powered by DSpace Copyright © 2002-2007 MIT and Hewlett-Packard | Compliant to OAI-PMH V 2.0

Home Page Total Visits: 623677 since 06-Feb-2009  Last updated on 13-Nov-2014Webmaster: nopr@niscair.res.in